Crystallization and preliminary crystallographic analysis of two eukaryotic fructosyl peptide oxidases.

Acta Crystallogr Sect F Struct Biol Cryst Commun

Research and Development Division, Kikkoman Corporation, 399 Noda, Noda-shi, Chiba 278-0037, Japan.

Published: February 2013

Fructosyl peptide oxidase (FPOX) catalyses the oxidation of α-glycated dipeptides such as N(α)-(1-deoxy-D-fructos-1-yl)-L-valyl-L-histidine (Fru-ValHis) and is used in the diagnosis of diabetes mellitus. Here, two thermostable mutants of FPOX, CFP-T7 and EFP-T5M, were crystallized by the sitting-drop vapour-diffusion method. The crystal of CFP-T7 belonged to the tetragonal space group P4(1)2(1)2, with unit-cell parameters a = b = 110.09, c = 220.48 Å, and that of EFP-T5M belonged to the monoclinic space group P2(1), with unit-cell parameters a = 43.00, b = 230.05, c = 47.27 Å, β = 116.99°. The crystals of CFP-T7 and EFP-T5M diffracted to 1.8 and 1.6 Å resolution, respectively.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564613PMC
http://dx.doi.org/10.1107/S1744309112051445DOI Listing

Publication Analysis

Top Keywords

fructosyl peptide
8
cfp-t7 efp-t5m
8
space group
8
unit-cell parameters
8
crystallization preliminary
4
preliminary crystallographic
4
crystallographic analysis
4
analysis eukaryotic
4
eukaryotic fructosyl
4
peptide oxidases
4

Similar Publications

Psoriasis, an immune-mediated chronic inflammatory skin disease, is primarily diagnosed through clinical assessment. Currently, specific markers for the accurate diagnosis and prediction of psoriatic disease are lacking. Here, we employed a three-step designed study to perform untargeted metabolomics, with the aim of identifying candidate biomarkers for psoriasis.

View Article and Find Full Text PDF

Glycated proteins are generated by binding of glucose to the proteins in blood stream through a nonenzymatic reaction. Hemoglobin A1c (HbA1c) is a glycated protein with glucose at the N-terminal of β-chain. HbA1c is extensively used as an indicator for assessing the blood glucose concentration in diabetes patients.

View Article and Find Full Text PDF

Evidence of Gas Phase Glucosyl Transfer and Glycation in the CID/HCD-Spectra of S-Glucosylated Peptides.

Int J Mol Sci

July 2024

Institute of Molecular and Industrial Biotechnology, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Stefanowskiego 2/22, 90-537 Łódź, Poland.

Protein cysteine S-glycosylation is a relatively rare and less well characterized post-translational modification (PTM). Creating reliable model proteins that carry this modification is challenging. The lack of available models or natural S-glycosylated proteins significantly hampers the development of mass-spectrometry-based (MS-based) methodologies for detecting protein cysteine S-glycosylation in real-world proteomic studies.

View Article and Find Full Text PDF

Comprehensive characterization of differential glycation in hepatocellular carcinoma using tissue proteomics with stable isotopic labeling.

Anal Bioanal Chem

August 2024

School of Chemical Science & Engineering, Shanghai Key Laboratory of Chemical Assessment and Sustainability, Tongji University, Shanghai, 200092, China.

Glycation is a non-enzymatic posttranslational modification coming from the reaction between reducing sugars and free amino groups in proteins, where early glycation products (fructosyl-lysine, FL) and advanced glycation end products (AGEs) are formed. The occurrence of glycation and accumulation of AGEs have been closely associated with hepatocellular carcinoma (HCC). Here, we reported the characterization of differential glycation in HCC using tissue proteomics with stable isotopic labeling; early glycation-modified peptides were enriched with boronate affinity chromatography (BAC), and AGEs-modified peptides were fractionated with basic reversed-phase separation.

View Article and Find Full Text PDF
Article Synopsis
  • Chinese patent medicines with Epimedii Folium and Psoraleae Fructus have been linked to idiosyncratic drug-induced liver injury (IDILI), but the specific toxic biomarkers and mechanisms are not well understood.
  • The study focused on the effects of bavachin and epimedin B from these plants on liver injury models induced by TNF-α, using both in vitro (cell cultures) and in vivo (mice) methods to measure liver damage.
  • Results indicated that combining bavachin and epimedin B exacerbated liver injury in TNF-α treated mice, shown by increased liver enzyme levels (ALT and AST) and inflammation, along with distinctive metabolites identified through metabolomics analysis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!